Objective: Tyrosinemia type 1 is a hereditary disorder with liver, kidney and nervous system involvement. Neurological crises can occur in tyrosinemic patients without treatment or when treatment stops. Here we report three children that developed diaphragmatic paralysis after discontinuation of nitisinone. In patients with tyrosinemia type 1, combined treatment with nitisinone and a low-tyrosine diet have prevented neurological crises. The purpose of this article was to express the importance of taking nitisinone (NTBC) for tyrosinemia diseases and risks of inadvertent discontinuation.

Materials & Methods: We describe three children referred to emergency department of Nemazee Hospital, Shiraz, Iran in December 2015 with tyrosinemia type 1 who stopped NTBC treatment, presenting with respiratory. Clinical findings, laboratory results, and imaging study were assessed in three patients on admission and after starting nitisinone.

Results: All patients developed diaphragmatic paralysis and respiratory distress after interruption of nitisinone treatment Two of the patients were improved after starting nitisinone. One patient expired due to respiratory failure. Full recovery occurred about 2 months after starting nitisinone.

Conclusion: Discontinuation of nitisinone can induce diaphragmatic paralysis and respiratory failure. Therefore, we should advise patients to use NTBC for the long term and not interrupt it.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703631PMC

Publication Analysis

Top Keywords

neurological crises
12
discontinuation nitisinone
12
tyrosinemia type
12
diaphragmatic paralysis
12
nitisinone ntbc
8
ntbc treatment
8
three children
8
developed diaphragmatic
8
paralysis respiratory
8
respiratory failure
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!